¼¼°èÀÇ ±¹¼Ò ¸¶ÃëÁ¦ ½ÃÀå : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)
Global Local Anesthesia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
»óǰÄÚµå : 1685702
¸®¼­Ä¡»ç : Mordor Intelligence Pvt Ltd
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,872,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF & Excel (Team License: Up to 7 Users) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷³» 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,500 £Ü 9,404,000
PDF & Excel (Site License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏÇÑ Áö¸®Àû À§Ä¡¿¡ ÀÖ´Â »ç¾÷Àå³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,750 £Ü 12,660,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ® µîÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ±¹¼Ò ¸¶ÃëÁ¦ ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 52¾ï 6,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ÀÎ 2025-2030³â CAGR 3.4%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 62¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Global Local Anesthesia Drugs-Market-IMG1

COVID-19¿¡ °¨¿°µÈ ȯÀÚÀÇ Ä¡·á¿¡¼­ ±¹¼Ò ¸¶ÃëÀÇ »ç¿ëÀº ±× ÀÌÁ¡°ú ¹ÙÀÌ·¯½º °¨¿°ÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÔÀ¸·Î½á ³ôÀº ¼ö¿ä°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 'COVID-19ÀÇ ±¸°­ ÀεΠ»ùÇøµÀ» À§ÇÑ ±¹¼Ò ¸®±×³ëÄ«ÀÎ ¸¶Ãë'¶ó´Â Á¦¸ñÀÇ 2020³â 10¿ù¿¡ ¹ßÇ¥µÈ ³í¹®¿¡ µû¸£¸é, ±¹¼Ò ±¸°­ ÀεΠ¸®±×³ëÄ«ÀÎ µµÆ÷´Â COVID-19ÀÇ ±¸°­ ÀεΠ»ùÇøµ Áß È¯ÀÚÀÇ ÄèÀû ¼öÁØÀ» À¯ÀÇÇÏ°Ô Áõ°¡½Ã۰í, µû¶ó¼­ º» Á¶»ç´Â COVID-19 °¨¿°ÀÌ ÀǽɵǴ »ç¶÷ÀÇ ¹ÙÀÌ·¯½º Á¢Á¾ »ùÇøµÀ» ÁÙÀ̱â À§ÇÑ ´ëÃ¥À¸·Î¼­ ±¹¼Ò ±¸°­ ÀεΠ¸®±×³ëÄ«ÀÎÀ» °í·ÁÇØ¾ß ÇÑ´Ù´Â °ÍÀ» ½Ã»çÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸´Â COVID-19 ȯÀÚÀÇ Ä¡·á¿¡¼­ ±¹¼Ò ¸¶ÃëÁ¦ÀÇ Åõ¿© ¹× »ç¿ëÀ» ¼¼°èÀûÀ¸·Î µÞ¹ÞħÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶ÇÇÑ ±¹¼Ò ¸¶ÃëÁ¦ ½ÃÀåÀÇ ¼ºÀåÀº ¼ö¼ú °Ç¼ö Áõ°¡, ¸¶ÃëÁ¦ ½Å±Ô ½ÂÀÎ ¹× ¼ö¼ú ÈÄ ÅëÁõ¿¡¼­ ±¹¼Ò ¸¶ÃëÁ¦ »ç¿ë Áõ°¡ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ¼ö¼ú °Ç¼ö Áõ°¡´Â Á¶»ç ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀ̾ú½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ(American Society of Plastic Surgeons)ÀÇ '¼ºÇü¿Ü°ú Åë°è º¸°í¼­'¿¡ µû¸£¸é 2020³â ¹Ì±¹¿¡¼­ ½Ç½ÃÇÑ ¹Ì¿ë ¼ºÇü ¼ö¼úÀÇ ÃѼö´Â 2,314,720°ÇÀ̾úÀ¸¸ç, ÀÌ Áß 211,067°ÇÀÇ Áö¹æ ÈíÀÔ ¼ö¼úÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼ú¿¡¼­´Â ±¹¼Ò ¸¶Ãë°¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ¼ö¼ú °Ç¼ö Áõ°¡´Â ¸¶ÃëÁ¦ ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù. °Ô´Ù°¡, »õ·Î¿î ±¹¼Ò ¸¶ÃëÁ¦ÀÇ °³¹ß ¹× ½ÂÀÎÀº ½ÃÀå ±â¾÷µé¿¡°Ô »õ·Î¿î ¼öÀÍ¿øÀÌ µÇ´Â °ÍÀ¸·Î ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 2¿ù ÆäÀÎÆÐ½º´Â ¸¸¼º ÅëÁõÀ» °¡Áø »ç¶÷µéÀ» ´ë»óÀ¸·Î ±ÙÀ°À» ¿ÜºÎ¿¡¼­ ¸¶ºñ½Ã۱â À§ÇÑ Ã¹ ¹øÂ° Ä­³ªºñµð¿Ã(CBD)/¸®µµÄ«ÀÎ Á¦Ç° ¶óÀÎÀ» Ãâ½ÃÇß½À´Ï´Ù.

±×·¯³ª ÀÌ·¯ÇÑ ¾à¹°ÀÇ ºÎÀÛ¿ë ¹× ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â Á¶»çµÈ ½ÃÀåÀ» ¾ïÁ¦ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±¹¼Ò ¸¶ÃëÁ¦ ½ÃÀå µ¿Çâ

ºÎÇǹÙÄ«ÀÎÀº ¿¹Ãø±â°£ µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾à¹° À¯Çüº°·Î´Â ºÎÇǹÙÄ«ÀÎÀÌ ¿¹Ãø ±â°£ Áß¿¡ Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÎÇǹÙÄ«ÀÎÀº ÅëÁõ ½ÅÈ£¸¦ ³ú·Î º¸³»´Â ½Å°æ Ãæµ¿À» Â÷´ÜÇÏ´Â ±¹¼Ò ¸¶ÃëÁ¦·Î »ç¿ëµÇ´Â 󹿾àÀÔ´Ï´Ù. ÀÌ ÁÖ»ç´Â ¼ö¼ú°ú Áø´Ü, Ä¡·á, »ê°ú Ä¡·á¿Í °°Àº ¿©·¯ Ä¡·áÀÇ ±¹¼Ò ¸¶Ãë ¹× ±¹ºÎ ¸¶Ãë·Î »ç¿ëµË´Ï´Ù. µû¶ó¼­ ¼¼°èÀûÀ¸·Î ¼ö¼ú °Ç¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ °¡±î¿î ¹Ì·¡¿¡ ºñÇÁºñÄÉÀÎ ¼ö¿ä°¡ ³ô¾ÆÁú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶ÇÇÑ, ¿©·¯ ½ÃÀå ±â¾÷µéÀÌ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ±¸ÇöÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 3¿ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº Pacira BioSciences Inc.°¡ Á¦ÃâÇÑ Exparel(ºÎÇǹÙÄ«ÀÎ ¸®Æ÷¼Ø ÁÖ»ç¿ë Çöʾ×)ÀÇ ¼Ò¾Æ ȯÀÚ¿¡ ´ëÇÑ »ç¿ë È®´ëÀÇ Ãß°¡ ½Å¾à ½ÂÀÎ ½Åû(sNDA)À» ½ÂÀÎÇß½À´Ï´Ù. µû¶ó¼­ ¼ö¼ú °Ç¼ö Áõ°¡ ¹× Á¦Ç° °³¹ßÀÌ ºñÇÁºñÄ«ÀÎ ¼ö¿ä¸¦ Áõ´ë½Ã۰í ÀÖ¾î ¿¹Ãø ±â°£ µ¿¾È °°Àº ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡ÇÏ°í ¿¹Ãø±â°£ µ¿¾Èµµ Áö¹è°¡ °è¼ÓµÉ Àü¸Á

ºÏ¹Ì¿¡¼­´Â ¹Ì±¹ÀÌ ½ÃÀåÀÇ ÁÖ¿ä Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¼ö¼ú °Ç¼ö Áõ°¡, ¸¸¼º ÁúȯÀ» ¾Î°í ÀÖ´Â °í·ÉÈ­ Àα¸ Áõ°¡, ¼ö¼ú ÈÄ ÅëÁõ¿¡¼­ÀÇ ±¹¼Ò ¸¶ÃëÁ¦ »ç¿ë Áõ°¡ ¹× ¸¶Ãë Åõ¿©ÀÇ Áøº¸ µî¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ(ASPS)¿¡ µû¸£¸é, 2020³â¿¡´Â 10-29¼¼¿¡ ¾à 76¸¸ 8000°ÇÀÇ ¹Ì¿ë ¼ºÇü ¼ö¼úÀÌ ÀÌ·ç¾îÁ³°í, 40-54¼¼¿¡¼­´Â 610¸¸ °ÇÀÇ ¹Ì¿ë ¼ºÇü ¼ö¼úÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ Åë°è´Â ÀÌ Áö¿ª¿¡¼­ ¼ö¼úÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ°í ¸¶Ä§³» ¸¶ÃëÁ¦ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

°Ô´Ù°¡, ¿©·¯ ½ÃÀå ±â¾÷µéÀÌ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ±¸ÇöÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 12¿ù, Hikma Pharmaceuticals PLC(Hikma)´Â ¹Ì±¹ °è¿­»ç Hikma Pharmaceuticals USA Inc.¸¦ ÅëÇØ ºÎÇǹÙÄ«ÀÎ ¿°»ê¿° ÁÖ»ç¾× USP¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ È¸»ç´Â 10ml¿Í 30mlÀÇ ¿ë·®À¸·Î 0.25%, 0.5%, 0.75%¸¦ Ãâ½ÃÇß½À´Ï´Ù.

ÀÌ·¯ÇÑ °³¹ßÀº ¸¶ÃëÁ¦¸¦ »ç¿ëÇÏ´Â ¼ö¼ú °Ç¼ö Áõ°¡¿Í ÇÔ²² ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±¹¼Ò ¸¶ÃëÁ¦ »ê¾÷ °³¿ä

±¹¼Ò ¸¶ÃëÁ¦ ½ÃÀåÀº ¿©·¯ ¼¼°è ±â¾÷µéÀÌ ÁøÀÔÇϰí ÀÖÀ¸¸ç ½ÃÀå °æÀïÀÌ ½ÉÇÕ´Ï´Ù. °¢ ȸ»ç´Â ½ÃÀå Á¡À¯À²À» È®´ëÇϱâ À§ÇØ ´ë±Ô¸ð Á¦ÈÞ, ÇÕº´ ¹× Àμö¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷Àº Fresenius SE & Co.KGaA, Septodont, Pfizer Inc., Baxter International Inc., Pacira Pharmaceuticals Inc.ÀÔ´Ï´Ù.

±âŸ ÇýÅÃ

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ½ÃÀå ¼¼ºÐÈ­

Á¦6Àå °æÀï ±¸µµ

Á¦7Àå ½ÃÀå ±âȸ ¹× ÇâÈÄ µ¿Çâ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Local Anesthesia Drugs Market size is estimated at USD 5.26 billion in 2025, and is expected to reach USD 6.22 billion by 2030, at a CAGR of 3.4% during the forecast period (2025-2030).

Global Local Anesthesia Drugs - Market - IMG1

The use of local anesthesia in treating patients infected with COVID-19 is in high demand due to its benefits and minimal risk of viral transmission. Additionally, as per an article published in October 2020, titled "Topical Lignocaine Anesthesia for Oropharyngeal Sampling for COVID-19," topical oropharyngeal lignocaine applications significantly increased comfort levels for the patient during oropharyngeal sampling for COVID-19 and did not affect the detection of SARS-CoV-2 in the upper airway. Thus, the study suggested that topical oropharyngeal lignocaine should be considered as a measure to reduce the viral inoculum sampling of a person suspected of being infected by COVID-19. Such studies are likely to boost the administration and use of local anesthesia drugs in treating COVID-19 patients globally.

Further, the growth of the local anesthesia drugs market is driven by various factors such as the rising number of surgeries, new approval of anesthetic drugs, and the growing use of local anesthetics in post-operative pain. The increasing number of surgeries was a major factor driving the market growth over the study period. For instance, as per the Plastic Surgery Statistics Report by the American Society of Plastic Surgeons, in 2020, the total number of cosmetic procedures performed were 2,314,720, including 211,067 procedures of liposuction in the US. As local anesthesia is widely used in such procedures, the growth in the number of such surgeries performed will propel the demand for anesthesia drugs. Furthermore, the development and approvals of novel local anesthesia drugs are proving to be a new revenue-generating resource for market players. For instance, in February 2021, PainPass launched the first Cannabidiol (CBD)/lidocaine product line targeting those with chronic pain and for numbing muscles externally.

However, the side effects of these drugs and strict regulatory framework are expected to restrain the market studied.

Local Anesthesia Drugs Market Trends

Bupivacaine Expected to Register Significant Growth over the Forecast Period

By drug type, bipuvicane is expected to witness significant growth over the forecast period. Bupivacaine is a prescription medication used as a local anesthetic to block the nerve impulses that send pain signals to the brain. This injection is used as an anesthetic for local and regional anesthesia for several procedures, such as surgery and diagnostic, therapeutic, and obstetrical procedures. Thus, the growing number of surgeries globally will fuel the demand for bipuvicane in the near future.

Furthermore, several market players are engaged in implementing strategic initiatives, thereby contributing to market growth. For instance, in March 2021, the US Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) submitted by Pacira BioSciences Inc. for the expanded use of its Exparel (Bupivacaine Liposome Injectable Suspension) in pediatric patients. Hence, the increasing number of surgeries and product developments is augmenting the demand for bipuvicane, and it is expected to propel the segment's growth over the forecast period.

North America Dominates the Market and Expected to Continue Dominance over the Forecast Period

Within North America, the US holds the major share of the market. This can be attributed to the increasing number of surgeries, the rising aging population suffering from chronic conditions, the growing use of local anesthetics in post-operative pain, and advancements in anesthesia administration. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2020, about 768,000 total cosmetic procedures were performed in people aged 10-29 years, and 6.1 million total cosmetic procedures were performed among the age group of 40-54-year-olds. These statistics indicate that surgical procedures are constantly increasing in the region, ultimately driving the demand for anesthesia drugs.

Moreover, several market players are also engaged in implementing strategic initiatives, which are contributing to market growth. For instance, in December 2021, Hikma Pharmaceuticals PLC (Hikma) launched Bupivacaine HCl Injection USP through its US affiliate Hikma Pharmaceuticals USA Inc. The company launched 0.25%, 0.5%, and 0.75% in 10 milliliter and 30 milliliter doses.

Such developments coupled with growth in the number of surgeries using anesthesia drugs are anticipated to bolster market growth in the region.

Local Anesthesia Drugs Industry Overview

The local anesthesia drugs market is competitive with several global players operating in the market. Companies are focusing on major collaborations, mergers, and acquisitions in order to enhance their market share. The major market players are Fresenius SE & Co. KGaA, Septodont, Pfizer Inc., Baxter International Inc., and Pacira Pharmaceuticals Inc.

Additional Benefits:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

5 MARKET SEGMENTATION (Market Size By Value - USD Million)

6 COMPETITIVE LANDSCAPE

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â